Italian radiopharmaceutical firm Bracco last month signed an agreement with Caffaro, the lead company of Italian firm Snia Group’s Chemical and Energy sector. The agreement allows Bracco to build a new plant on the site of Industrie Chimiche Caffaro
Italian radiopharmaceutical firm Bracco last month signed an agreement with Caffaro, the lead company of Italian firm Snia Groups Chemical and Energy sector. The agreement allows Bracco to build a new plant on the site of Industrie Chimiche Caffaro in Torviscosa. The plant will manufacture Braccos imaging contrast media products, and Bracco will use the raw materials, utilities, facilities, and services already available at the site. The plant will eventually employ approximately 100 people.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.